Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Under Investigation By New York AG Spitzer

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer is under investigation by the New York State Attorney General for possible off-label promotion

You may also be interested in...



Brand Rx Prices Increased Half A Percent On Average From July To September

AARP/University of Minnesota pricing survey finds the average rate of increase for 197 drugs slowed in comparison to the 1% rise in prices between April and June and the 3.5% increase observed from January to March.

Aggressive Patents Should Have Senior Management Support, Pfizer Attorney Says

Management should "buy-in" before controversial patents that could delay generic entry are listed, Pfizer Senior Patent Counsel Pokras says. Pokras suggests that some people, including state prosecutors, would not see the "connection" between a patent on a metered dose device and the drug product.

Aggressive Patents Should Have Senior Management Support, Pfizer Attorney Says

Management should "buy-in" before controversial patents that could delay generic entry are listed, Pfizer Senior Patent Counsel Pokras says. Pokras suggests that some people, including state prosecutors, would not see the "connection" between a patent on a metered dose device and the drug product.

Related Content

Topics

UsernamePublicRestriction

Register

SC141925

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel